SCHEMBL3404983

SCHEMBL3404983

CCCCCCCc1cccc(OC(=O)CN)c1

nearest known ligand 0.61

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 8/20 0.61
PPARG P37231 5/20 0.61
ACHE P22303 3/20 0.51
CNR1 P21554 1/20 0.49
CNR2 P34972 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29328712 0.89 PPARA (0.64) PPARAPPARGCNR1CNR2
SCHEMBL29328702 0.87 PPARA (0.63) PPARAPPARGCNR1CNR2
SCHEMBL28392302 0.87 PPARA (0.63) PPARAPPARGCNR1CNR2
SCHEMBL29328706 0.87 PPARA (0.63) PPARAPPARGCNR1CNR2
SCHEMBL29328704 0.87 PPARA (0.63) PPARAPPARGCNR1CNR2
SCHEMBL28337010 0.87 PPARA (0.62) PPARAPPARGACHECNR1CNR2
Bromide SCHEMBL28328576 0.86 PPARA (0.61) PPARAPPARGCNR1CNR2
SCHEMBL646706 0.86 PPARA (0.64) PPARAPPARGACHECNR1CNR2
SCHEMBL29914202 0.85 PPARA (0.68) PPARAPPARGCNR1CNR2
SCHEMBL29943880 0.85 PPARA (0.68) PPARAPPARGCNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10675278-B2 Crush resistant delayed-release dosage forms Grünenthal GmbH (DE) 2020-06-09 US disclosed
US-20180369235-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2018-12-27 US disclosed
US-20170312271-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2017-11-02 US disclosed
US-9750701-B2 Pharmaceutical dosage form Grünenthal GmbH (DE) 2017-09-05 US disclosed
US-20160199305-A1 PHARMACEUTICAL DOSAGE FORM Grünenthal GmbH (DE) 2016-07-14 US disclosed
US-20160184297-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2016-06-30 US disclosed
US-20160120810-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2016-05-05 US disclosed
US-20150374630-A1 Crush resistant delayed-release dosage forms GRUENENTHAL GMBH (DE) 2015-12-31 US disclosed
US-20150290138-A1 Crush resistant delayed-release dosage forms Grünenthal GmbH (DE) 2015-10-15 US disclosed
US-20140322311-A1 CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM Grünenthal GmbH (DE) 2014-10-30 US disclosed
US-20140112984-A1 Crush resistant delayed-release dosage forms GRUENENTHAL GMBH (DE) 2014-04-24 US disclosed
US-20140079780-A1 Crush resistant delayed-release dosage forms GRUENENTHAL GMBH (DE) 2014-03-20 US disclosed
US-20130251759-A1 PHARMACEUTICAL DOSAGE FORM GRUENENTHAL GMBH (DE) 2013-09-26 US disclosed
US-8383152-B2 Pharmaceutical dosage form GRUENENTHAL GMBH (DE) 2013-02-26 US disclosed
EP-2249811-A1 PHARMACEUTICAL DOSAGE FORM Grünenthal GmbH (DE) 2010-11-17 EP disclosed
US-20100151028-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS GRUNENTHAL GMBH (DE) 2010-06-17 US disclosed
US-20090202634-A1 PHARMACEUTICAL DOSAGE FORM GRUNENTHAL GMBH (DE) 2009-08-13 US disclosed
WO-2009092601-A1 PHARMACEUTICAL DOSAGE FORM Grünenthal GmbH (DE) 2009-07-30 WO disclosed
US-20080311187-A1 CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM GRUNENTHAL GMBH (DE) 2008-12-18 US disclosed
US-20060193914-A1 Crush resistant delayed-release dosage forms ENDO PHARMACEUTICALS, INC. 2006-08-31 US disclosed